At a glance
Globe Life Inc is worth $12.28B, about 11 times its fiscal 2025 earnings. Revenue grew 3.7% to $5.99B in fiscal 2025, with 19.4% kept as profit; over 5 years it has grown 4.8% a year. It pays a 0.79% dividend yield, raised every year for at least 9 years, and returned $3.81B to shareholders in dividends and buybacks over FY2021–FY2025. The stock returned +22.5% over the past year with dividends reinvested and +12.6% a year over five years, against +11.5% and +11.7% for the S&P 500. At its worst it fell 47.7% in the 2020 crash (S&P 500: 33.7%) and 16.6% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 31 months and 4 months after the lows.
The business in plain English
Globe Life Inc., formerly Torchmark, is an insurance holding company selling life and supplemental health insurance to lower middle-income and middle-income Americans. It has five divisions: Direct to Consumer (mail, electronic and insert media); American Income Life, aimed at working families, with 11,920 average producing agents in the U.S., Canada and New Zealand; Liberty National, selling in homes and workplaces (3,846 agents); Family Heritage, supplemental health (1,527 agents); and United American, mainly Medicare Supplement (4,396 independent agents). American Income, Liberty National and Family Heritage agents are independent contractors who sell only for Globe Life.
Revenue, $5.99 billion for the year ended December 31, 2025, comes mostly from premiums, plus income from investing premiums before claims are paid; about 86% of invested assets were fixed maturities (bonds). With no clean revenue split by segment in the 10-K, annualized premium in force (a year's premiums on policies still on the books) shows the mix. At December 31, 2025, traditional whole life made up 71% of life premium and term life 22%, with American Income the largest life channel. In health, limited-benefit plans such as cancer, accident and critical-illness cover made up 54%, and Medicare Supplement 46%.
Globe Life credits below-peer selling and overhead costs for its competitive prices. The catch: growth depends on recruiting agents, and authorities could deem its contractors employees.
Price history
The interactive chart needs JavaScript.
GL +22.5% over the year to Nov 2, 2026, total return with dividends reinvested.
Latest results
- In Q2 FY2026 (ended Jun 30, 2026), revenue was $1.60B, up 8% from a year earlier, and net income was $287.7M (+13.8%).
- For fiscal 2025, revenue was $5.99B (+3.7% year over year; +4.8% a year from FY2020 to FY2025) with a 19.4% net margin.
Financial health check
| Revenue growth a year (FY2020–FY2025) | +4.8% watch |
|---|---|
| Free cash flow margin | 20.9% good |
| Return on equity (FY2025) | 19.4% good |
| Return on assets (FY2025) | 3.8% watch |
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2020 | $4.74B | $731.8M | $1.43B |
| FY2021 | $5.11B | $1.03B | $1.40B |
| FY2022 | $5.23B | $894.4M | $1.39B |
| FY2023 | $5.45B | $970.8M | $1.43B |
| FY2024 | $5.78B | $1.07B | $1.33B |
| FY2025 | $5.99B | $1.16B | $1.25B |
Valuation snapshot
| Market value | $12.28B |
|---|---|
| P/E ratio | 11.4 |
| Dividend yield | 0.79% |
Rank among 1514 US companies
Market value at each year end
Globe Life’s market value went from $8.75B at the end of 2016 to $12.28B on Nov 2, 2026, up 40%; since the end of 2025 it is up 10%.
Show as a table
| Year end | Market value | Change |
|---|---|---|
| Nov 2, 2026 | $12.28B | +10.3% |
| 2025 | $11.13B | +18.9% |
| 2024 | $9.36B | -18.3% |
| 2023 | $11.46B | -2.3% |
| 2022 | $11.73B | +23.9% |
| 2021 | $9.46B | -4.8% |
| 2020 | $9.94B | -12.8% |
| 2019 | $11.40B | +37.1% |
| 2018 | $8.31B | -20.6% |
| 2017 | $10.47B | +19.7% |
| 2016 | $8.75B |
Price behavior
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | |
|---|---|---|---|---|---|
| GL price data to Nov 2, 2026 | +15.2% | +22.5% | +12.3% | +12.6% | +10.6% |
Show as a table
| Year | Price data |
|---|---|
| 2026 (to date) | +15.2% |
| 2025 | +26.5% |
| 2024 | -7.5% |
| 2023 | +1.8% |
| 2022 | +29.7% |
| 2021 | -0.3% |
| 2020 | -8.9% |
| 2019 | +42.3% |
| 2018 | -17.2% |
| 2017 | +23.9% |
| 2016 | +30.3% |
| 2015 | +6.3% |
| 2014 | +4.8% |
| 2013 | +53.2% |
| 2012 | +20.5% |
| 2011 | +10.1% |
| 2010 | +37.6% |
| 2009 | -0.5% |
| 2008 | -25.4% |
| 2007 | -4.7% |
| 2006 | +15.1% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Lost 72.4% over that stretch · deepest drop along the way 73.7%, back to its old high 22.7 months after the low |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Lost 47.4% over that stretch · deepest drop along the way 47.7%, back to its old high 30.7 months after the low |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Gained 13.5% over that stretch · deepest drop along the way 16.6%, back to its old high 3.7 months after the low |
Insider activity
Form 4 filings from 2025-10-29 to 2026-10-29 (25 read): 0 open-market purchases and 55 sales ($63.0M).
| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 31, 2026 | James Matthew Darden Co-Chairman & CEO, Director | sell | $9.0M |
| Jul 29, 2026 | Michael Clay Majors EVP - Chief Strategy Officer | sell | $6.0M |
| May 22, 2026 | Frank M Svoboda Co-Chairman & CEO, Director | sell | $2.9M |
| Apr 24, 2026 | Michael Clay Majors EVP - Chief Strategy Officer | sell | $2.7M |
| Oct 23, 2026 | Michael Clay Majors EVP - Chief Strategy Officer | sell | $2.2M |
Who owns it
Large shareholders (13G filings)
| Vanguard Capital Management | 7.45% | Mar 31, 2026 |
| Vanguard Portfolio Management | 5.44% | Mar 31, 2026 |
| Invesco Ltd. | 5.1% | Mar 31, 2026 |
| Wellington Management Group LLP | 4.8% | Jun 30, 2025 |
ETFs with the most weight in GL
| USSE Segall Bryant & Hamill Select Equity ETF | 4.98% |
| LSAT Leadershares Alphafactor Tactical Focused ETF | 3.26% |
| YOKE YOKE Core ETF | 1.95% |
| KIE SPDR S&P Insurance ETF | 1.91% |
| LEAD Siren DIVCON Leaders Dividend ETF | 1.64% |
| RSPF Invesco S&P 500 Equal Weight Financials ETF | 1.4% |
| IAK iShares U.S. Insurance ETF | 1.19% |
| TAX Cambria Tax Aware ETF | 1.08% |
What could go wrong
- Agents could be ruled employees. Many agents are independent contractors. In September 2024 the EEOC, a federal agency, said agents under one general agent were employees. The finding isn't binding, but reclassification could sharply raise costs.
- Short sellers and lawsuits can hit shares. The 10-K says short sellers, who profit when shares fall, have driven down the stock, and that price swings have led to class action lawsuits. Agent misconduct claims add further legal risk.
- Sales depend on agents and niche markets. Growth relies on recruiting and motivating agents, and on niches such as labor unions, affinity groups and direct-to-consumer buyers. Weak recruiting or fraying ties with these groups could slow sales.
- Health rate increases need timely approval. Some supplemental health policies need regulator-approved rate increases. If approvals come late or fall short as claim costs rise, margins could shrink. Health premium in force was $1.65 billion at end-2025.
- Claims could exceed pricing assumptions. Prices assume how many policyholders will die, fall ill or drop coverage. Worse-than-expected deaths, illness claims or lapses, including from a pandemic or other catastrophe, could hurt results.
- Investment losses and interest-rate swings. About 86% of invested assets were bonds at December 31, 2025. Defaults, downgrades or rate changes could cut investment income, and some alternative investments may be hard to sell and volatile.
Recent events
- Quarterly results released
- Executive or board change
- Quarterly results released
- Major agreement signed
- Executive or board change; Shareholder vote results
- Quarterly results released
- Executive or board change
- Quarterly results released
- Executive or board change
For income and retirement investors
Globe Life's dividend is small but growing. Dividends per share rose in every fiscal year from 2016 to 2025, at least nine straight increases, reaching $1.08 in 2025, up from $0.75 in 2020. That used 7.4% of earnings and 6.9% of free cash flow (cash left after running the business). With a 0.8% yield as of October 28, 2026, the stock offers little income. Buybacks get far more: $3.39 billion over fiscal 2021–2025, versus $416 million in dividends, cutting the share count by about 24% since 2021.
The shares have fallen hard in crises: 73.7% in the 2008 financial crisis and 47.7% in the 2020 COVID crash, taking about 23 and 31 months from the bottom to recover. In the 2022 bear market they gained 13.5% from the market's peak to its low. They fell as much as 61.6% in the three years to October 28, 2026. A single stock carries more risk than a diversified fund.
Questions investors ask
How does Globe Life make money?
Globe Life sells life and supplemental health insurance to lower middle-income and middle-income families. It invests the premiums, mostly in high-quality bonds, until claims come due. Agents who sell only for American Income Life, Liberty National and Family Heritage do much of the selling. Independent agents sell for United American, and the Direct to Consumer division uses mail and electronic media. In fiscal 2025 it had revenue of $5.99 billion and net income of $1.16 billion, a net margin of 19.4%.
Does Globe Life raise its dividend every year?
Yes, for at least nine years. Dividends per share rose in every fiscal year from 2016 through 2025, and the streak may be longer. The payout reached $1.08 per share in 2025, up from $0.75 in 2020, or about 7.6% growth a year. The dividend is small compared with profits: it used 7.4% of 2025 net income and 6.9% of free cash flow. That low payout leaves room to keep raising it, though increases are never guaranteed.
Why is Globe Life's dividend yield so low?
Globe Life's dividend yield was 0.8% as of October 28, 2026. The main reason is that it pays out a small share of profits as dividends and returns far more cash through buybacks. Over fiscal 2021–2025 it spent $3.39 billion buying back shares and $416 million on dividends. The share count fell about 24% between October 2021 and July 2026, which raises each remaining share's claim on earnings. For income investors, the stock supplies little cash, so most of any return depends on the share price.
Is Globe Life the same company as Torchmark?
Yes. Globe Life Inc. was formerly named Torchmark Corp. It is an insurance holding company incorporated in Delaware in 1979, and its shares trade on the New York Stock Exchange under the ticker GL. Its main subsidiaries are Globe Life And Accident Insurance Company, American Income Life, Liberty National Life, Family Heritage Life and United American Insurance. Globe Life And Accident, based in McKinney, Texas, runs the company's Direct to Consumer division.
Why has Globe Life stock been so volatile?
The company's 10-K points to short sellers. It says short-selling strategies have driven down its share price, and that price swings have led to securities class action lawsuits. Globe Life also faces disputes over whether its agents are contractors or employees. These include a September 2024 EEOC finding about agents under one general agent. The shares fell as much as 61.6% within the three years to October 28, 2026, yet the price rose 18.8% over the 12 months to that date.